Byeong Hyeok Choi

1.1k total citations
30 papers, 855 citations indexed

About

Byeong Hyeok Choi is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Byeong Hyeok Choi has authored 30 papers receiving a total of 855 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 8 papers in Oncology and 5 papers in Cancer Research. Recurrent topics in Byeong Hyeok Choi's work include PI3K/AKT/mTOR signaling in cancer (7 papers), Ubiquitin and proteasome pathways (4 papers) and Nanoparticles: synthesis and applications (4 papers). Byeong Hyeok Choi is often cited by papers focused on PI3K/AKT/mTOR signaling in cancer (7 papers), Ubiquitin and proteasome pathways (4 papers) and Nanoparticles: synthesis and applications (4 papers). Byeong Hyeok Choi collaborates with scholars based in United States, South Korea and United Kingdom. Byeong Hyeok Choi's co-authors include Soon Young Shin, Yoongho Lim, Wei Dai, Young Han Lee, Chang Gun Kim, Young Han Lee, Changyan Chen, Sang Wook Son, Michele Pagano and Young‐Seuk Bae and has published in prestigious journals such as Journal of Biological Chemistry, Cancer Research and Scientific Reports.

In The Last Decade

Byeong Hyeok Choi

29 papers receiving 836 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Byeong Hyeok Choi United States 16 498 222 107 101 89 30 855
Qing Wu China 15 456 0.9× 75 0.3× 70 0.7× 73 0.7× 83 0.9× 44 734
Shilpi Saha India 16 486 1.0× 253 1.1× 55 0.5× 115 1.1× 160 1.8× 20 987
Argha Manna India 10 363 0.7× 220 1.0× 53 0.5× 47 0.5× 150 1.7× 13 589
Shengjie Xu China 18 631 1.3× 248 1.1× 41 0.4× 36 0.4× 263 3.0× 33 1.4k
Rehan M. Villani Australia 9 436 0.9× 125 0.6× 60 0.6× 16 0.2× 130 1.5× 19 787
Sreenivas Nannapaneni United States 18 576 1.2× 274 1.2× 27 0.3× 44 0.4× 149 1.7× 37 995
Xinyi Huang China 12 422 0.8× 107 0.5× 74 0.7× 16 0.2× 102 1.1× 37 826
Ting Lan China 19 632 1.3× 153 0.7× 27 0.3× 33 0.3× 255 2.9× 77 1.1k
Hélène Therriault Canada 15 231 0.5× 166 0.7× 40 0.4× 20 0.2× 144 1.6× 22 644

Countries citing papers authored by Byeong Hyeok Choi

Since Specialization
Citations

This map shows the geographic impact of Byeong Hyeok Choi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Byeong Hyeok Choi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Byeong Hyeok Choi more than expected).

Fields of papers citing papers by Byeong Hyeok Choi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Byeong Hyeok Choi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Byeong Hyeok Choi. The network helps show where Byeong Hyeok Choi may publish in the future.

Co-authorship network of co-authors of Byeong Hyeok Choi

This figure shows the co-authorship network connecting the top 25 collaborators of Byeong Hyeok Choi. A scholar is included among the top collaborators of Byeong Hyeok Choi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Byeong Hyeok Choi. Byeong Hyeok Choi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Peng, Xiandong, et al.. (2024). KRas plays a negative role in regulating IDO1 expression. Translational Oncology. 51. 102167–102167. 1 indexed citations
2.
Choi, Byeong Hyeok, et al.. (2024). Enzyme-independent role of EZH2 in regulating cell cycle progression via the SKP2-KIP/CIP pathway. Scientific Reports. 14(1). 13389–13389. 2 indexed citations
3.
Chen, Fei, et al.. (2024). AhR signaling modulates Ferroptosis by regulating SLC7A11 expression. Toxicology and Applied Pharmacology. 486. 116936–116936. 10 indexed citations
4.
Yang, Rui, et al.. (2022). Oxidative stress modulates expression of immune checkpoint genes via activation of AhR signaling. Toxicology and Applied Pharmacology. 457. 116314–116314. 15 indexed citations
5.
Lee, Eunji, et al.. (2022). MicroRNA–Gene Interactions Impacted by Toxic Metal(oid)s during EMT and Carcinogenesis. Cancers. 14(23). 5818–5818. 7 indexed citations
6.
Lee, Eunji, et al.. (2022). Expression of IDO1 is regulated via Ras signaling pathways. The FASEB Journal. 36(S1). 2 indexed citations
7.
Dai, Wei, Suqing Xie, Changyan Chen, & Byeong Hyeok Choi. (2021). Ras sumoylation in cell signaling and transformation. Seminars in Cancer Biology. 76. 301–309. 16 indexed citations
8.
Choi, Byeong Hyeok, et al.. (2021). Identification of Radil as a Ras binding partner and putative activator. Journal of Biological Chemistry. 296. 100314–100314. 8 indexed citations
9.
Choi, Byeong Hyeok, et al.. (2018). K-Ras Lys-42 is crucial for its signaling, cell migration, and invasion. Journal of Biological Chemistry. 293(45). 17574–17581. 37 indexed citations
10.
Choi, Byeong Hyeok, et al.. (2017). PTEN is a negative regulator of mitotic checkpoint complex during the cell cycle. Experimental Hematology and Oncology. 6(1). 19–19. 12 indexed citations
11.
Choi, Byeong Hyeok, Michele Pagano, & Wei Dai. (2014). Plk1 Protein Phosphorylates Phosphatase and Tensin Homolog (PTEN) and Regulates Its Mitotic Activity during the Cell Cycle. Journal of Biological Chemistry. 289(20). 14066–14074. 46 indexed citations
12.
Choi, Byeong Hyeok, Michele Pagano, Chuanshu Huang, & Wei Dai. (2014). Cdh1, a Substrate-recruiting Component of Anaphase-promoting Complex/Cyclosome (APC/C) Ubiquitin E3 Ligase, Specifically Interacts with Phosphatase and Tensin Homolog (PTEN) and Promotes Its Removal from Chromatin. Journal of Biological Chemistry. 289(25). 17951–17959. 19 indexed citations
13.
Choi, Byeong Hyeok, Changyan Chen, & Wei Dai. (2013). Chromatin PTEN is involved in DNA damage response partly through regulating Rad52 sumoylation. Cell Cycle. 12(21). 3442–3447. 32 indexed citations
14.
Park, Yoon-Hee, Sang Hoon Jeong, Sang Min Yi, et al.. (2011). Analysis for the potential of polystyrene and TiO2 nanoparticles to induce skin irritation, phototoxicity, and sensitization. Toxicology in Vitro. 25(8). 1863–1869. 54 indexed citations
15.
Bae, Hyun Cheol, Hwa Jung Ryu, Sang Hoon Jeong, et al.. (2011). Oxidative stress and apoptosis induced by ZnO nanoparticles in HaCaT cells. Molecular & Cellular Toxicology. 7(4). 333–337. 15 indexed citations
16.
Park, Yoon-Hee, Ji Na Kim, Sang Hoon Jeong, et al.. (2009). Assessment of dermal toxicity of nanosilica using cultured keratinocytes, a human skin equivalent model and an in vivo model. Toxicology. 267(1-3). 178–181. 58 indexed citations
17.
Choi, Byeong Hyeok, et al.. (2008). p21Waf1/Cip1 Expression by Curcumin in U-87MG Human Glioma Cells: Role of Early Growth Response-1 Expression. Cancer Research. 68(5). 1369–1377. 114 indexed citations
18.
Choi, Byeong Hyeok, Chang Gun Kim, Yoongho Lim, Soon Young Shin, & Young Han Lee. (2007). Curcumin down-regulates the multidrug-resistance mdr1b gene by inhibiting the PI3K/Akt/NFκB pathway. Cancer Letters. 259(1). 111–118. 192 indexed citations
19.
20.
Shin, Soon Young, Byeong Hyeok Choi, Jesang Ko, et al.. (2006). Clozapine, a neuroleptic agent, inhibits Akt by counteracting Ca2+/calmodulin in PTEN-negative U-87MG human glioblastoma cells. Cellular Signalling. 18(11). 1876–1886. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Qing Wu Breakdown of academic impact, for papers by Shilpi Saha Breakdown of academic impact, for papers by Argha Manna Breakdown of academic impact, for papers by Shengjie Xu Breakdown of academic impact, for papers by Rehan M. Villani Breakdown of academic impact, for papers by Sreenivas Nannapaneni Breakdown of academic impact, for papers by Xinyi Huang Breakdown of academic impact, for papers by Ting Lan Breakdown of academic impact, for papers by Hélène Therriault
Rankless by CCL
2026